Cargando…

Correction to: The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Detalles Bibliográficos
Autores principales:	Auffret, Manon, Drapier, Sophie, Vérin, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995790/ https://www.ncbi.nlm.nih.gov/pubmed/29737467 http://dx.doi.org/10.1007/s40268-018-0233-0

Ejemplares similares

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
por: Auffret, Manon, et al.
Publicado: (2018)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

Correction: Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S., et al.
Publicado: (2018)

Correction: Regulation of dopaminergic function: An [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S, et al.
Publicado: (2019)

Apomorphine
Publicado: (1900)

Apomorphine
Publicado: (1888)

Correction: Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

Night‐Time Apomorphine Infusion: Who Are the Best Candidates?
por: Cochen De Cock, Valérie, et al.
Publicado: (2023)

Correction: T cell clonality assessment: past, present and future
Publicado: (2018)

Correction: Selective laser trabeculoplasty: past, present, and future
por: Garg, A., et al.
Publicado: (2019)

Correction to: A Perfect Storm? Health Anxiety, Contamination Fears, and COVID-19: Lessons Learned from Past Pandemics and Current Challenges
por: Dennis, Danielle, et al.
Publicado: (2021)

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
por: Zagnoli, Fabien, et al.
Publicado: (2023)

Correction: The many faces of hematopoietic stem cell heterogeneity. Development doi: 10.1242/dev.114231
por: Crisan, Mihaela, et al.
Publicado: (2017)

Correction to: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces
por: Grünert, Sarah C., et al.
Publicado: (2022)

Apomorphine effects on the hippocampus
por: Arroyo-García, Luis Enrique, et al.
Publicado: (2018)

On the Anæsthetic Action of Apomorphine
Publicado: (1885)

Correction to: Advances in anesthesia technology are improving patient care, but many challenges remain
por: John Doyle, D., et al.
Publicado: (2018)

Enhanced Impulsive Action Selection in Middle-Aged Adults—Insights From an Oculomotor Simon Task
por: Duprez, Joan, et al.
Publicado: (2016)

Correction: Evolution of therapies for the corneal endothelium: past, present and future approaches
Publicado: (2023)

Evaluating Cognitive Action Control Using Eye-Movement Analysis: An Oculomotor Adaptation of the Simon Task
por: Duprez, Joan, et al.
Publicado: (2016)

Hunting human disease genes: lessons from the past, challenges for the future
por: Brunham, Liam R., et al.
Publicado: (2013)

Functional Brain Dysconnectivity in Parkinson's Disease: A 5‐Year Longitudinal Study
por: Yassine, Sahar, et al.
Publicado: (2022)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Some Observations on the Use of Apomorphine
por: Horsley, J. S.
Publicado: (1912)

Is Apomorphine a Safe Emetic?
por: Brown, John
Publicado: (1889)

Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
por: Henriksen, Tove, et al.
Publicado: (2023)

Oral Health Disorders in Parkinson’s Disease: More than Meets the Eye
por: Auffret, Manon, et al.
Publicado: (2021)

Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty
por: Auffret, Manon, et al.
Publicado: (2023)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
por: Borkar, Nrupa, et al.
Publicado: (2018)

Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia
por: Duval, Fabrice
Publicado: (2023)

Lessons from the past: pathways to the future
por: Winter, Robert B.
Publicado: (2009)

Past, Present, and Future of Veterinary Epidemiology and Economics: One Health, Many Challenges, No Silver Bullets
por: Perez, Andres M.
Publicado: (2015)

Correction: Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Publicado: (2021)

Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Zamò, Alberto, et al.
Publicado: (2023)

Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
por: Agbo, Felix, et al.
Publicado: (2021)

Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice
por: Kobylecki, Christopher, et al.
Publicado: (2023)

Apomorphine Hydrochloride in the Treatment of Persistent Hiccough
por: Panda, R. C.
Publicado: (1928)

The Pharmacological Properties and Therapeutic Use of Apomorphine
por: Ribarič, Samo
Publicado: (2012)

Apomorphine in Parkinson's Disease—The Questions Raised
por: Dhamija, Rajinder K., et al.
Publicado: (2020)

Looking Beyond the Fog—Apomorphine Demystified
por: LK, Prashanth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c11r9ovqfsmkt2qa7isjnq1q2h